Benzoyl peroxide
Acanya, Benzamycin, Duac, Epiduo, Epsolay, Onexton, Twyneo (benzoyl peroxide) is a small molecule pharmaceutical. Benzoyl peroxide was first approved as Benzamycin on 1984-10-26. It is used to treat acne vulgaris and rosacea in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
---|---|
skin and connective tissue diseases | D017437 |
Trade Name
FDA
EMA
Epsolay
CombinationsAcanya, Benzamycin, Duac, Epiduo, Onexton, Twyneo (generic drugs available since 2009-08-11, discontinued: Aktipak, Benzaclin)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Adapalene
+
Benzoyl peroxide
Benzoyl peroxide
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
EPSOLAY | Galderma | N-214510 RX | 2022-04-22 | 1 products, RLD, RS |
Benzoyl peroxide
+
Clindamycin phosphate
Benzoyl peroxide
+
Erythromycin
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
BENZAMYCIN | Bausch Health Companies | N-050557 RX | 1984-10-26 | 1 products, RLD, RS |
Show 1 discontinued
Benzoyl peroxide
+
Tretinoin
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
TWYNEO | Galderma | N-214902 RX | 2021-07-26 | 1 products, RLD, RS |
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
acanya | New Drug Application | 2020-09-30 |
benzaclin | New Drug Application | 2017-02-16 |
benzamycin | New Drug Application | 2020-11-30 |
epiduo forte | New Drug Application | 2019-11-26 |
epsolay | New Drug Application | 2022-09-15 |
onexton | New Drug Application | 2020-04-06 |
twyneo | New Drug Application | 2022-03-15 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
acne vulgaris | EFO_0003894 | D000152 | L70 |
rosacea | — | D012393 | L71 |
Agency Specific
FDA
EMA
Expiration | Code | ||
---|---|---|---|
BENZOYL PEROXIDE, EPSOLAY, GALDERMA LABS LP | |||
2025-04-22 | NP | ||
BENZOYL PEROXIDE / TRETINOIN, TWYNEO, GALDERMA LABS LP | |||
2024-07-26 | NC | ||
BENZOYL PEROXIDE / CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE, ENCUBE | |||
2023-03-13 | CGT |
Patent Expiration
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Benzoyl Peroxide, Epsolay, Galderma Labs Lp | |||
11628155 | 2040-12-27 | U-3356 | |
11426378 | 2040-08-18 | U-3356 | |
10933046 | 2040-02-19 | DP | U-3357 |
10945987 | 2040-02-19 | U-3356 | |
11541026 | 2040-02-19 | U-3356 | |
9687465 | 2032-11-27 | DP | U-3356 |
9868103 | 2028-08-08 | DP | U-3194, U-3356 |
Benzoyl Peroxide / Tretinoin, Twyneo, Galderma Labs Lp | |||
10420743 | 2038-07-12 | U-3194 | |
10653899 | 2030-12-30 | DP | U-3194 |
11071878 | 2030-12-30 | DP | |
8617580 | 2028-02-03 | DP | |
Benzoyl Peroxide / Clindamycin Phosphate, Acanya, Bausch | |||
8288434 | 2029-08-05 | DP | U-124, U-134, U-818, U-916, U-921, U-1033 |
8663699 | 2029-06-03 | U-124 | |
8895070 | 2029-06-03 | U-124 | |
9078870 | 2029-06-03 | DP | |
9504704 | 2029-06-03 | DP | U-124, U-134, U-818, U-916 |
9561208 | 2029-06-03 | DP | U-916 |
10137142 | 2029-06-03 | DP | U-916 |
10220049 | 2029-06-03 | DP | U-916 |
10624918 | 2029-06-03 | U-916 | |
Adapalene / Benzoyl Peroxide, Epiduo, Galderma Labs Lp | |||
8071644 | 2027-07-18 | DP | U-1078 |
8080537 | 2027-07-18 | U-1078 | |
8129362 | 2027-07-18 | U-1078 | |
8445543 | 2027-07-12 | U-1078 | |
7820186 | 2025-11-23 | DP | |
7964202 | 2024-09-01 | DP | U-1078 |
Adapalene / Benzoyl Peroxide, Epiduo Forte, Galderma Labs | |||
8703820 | 2023-03-12 | U-1078 | |
8729127 | 2023-03-12 | U-1078 | |
9381179 | 2023-03-12 | U-1078 | |
9387187 | 2023-03-12 | U-1078 |
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | BENZOYL PEROXIDE |
INN | — |
Description | Benzoyl peroxide is a carbonyl compound. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | O=C(OOC(=O)c1ccccc1)c1ccccc1 |
Identifiers
PDB | — |
CAS-ID | 94-36-0 |
RxCUI | 1418 |
ChEMBL ID | CHEMBL1200370 |
ChEBI ID | 82405 |
PubChem CID | 7187 |
DrugBank | DB09096 |
UNII ID | — |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 3,941 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
1 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more